HRA Pharma Reveals Big Growth Ambitions In Quest To Become Top-10 OTC Player
Executive Summary
A combination of prescription-to-OTC switches, acquisitions and maximising the potential of its existing portfolio will take France’s HRA Pharma to the next level, reveals chief commercial officer Martyn Hilton.
You may also be interested in...
Perrigo Continues Overhaul Adding HRA Pharma, Boosts Chances For OTC Oral Contraceptive In US
HRA’s approval for pharmacy sales of a daily oral contraceptive the UK and its ongoing work on an NDA to propose making another progestin-only contraceptive ingredient available OTC in the US stand out as additions to Perrigo’s business with the most substantial revenue impacts.
South Africa Next As HRA Pharma Marches On With Global Expansion
HRA Pharma brings Compeed to South Africa, moving the company one step closer to achieving its goal of becoming a top-10 global consumer healthcare player.
HRA Pharma Expands Footprint With Middle East Move
France's HRA is looking to tap into consumer demand for foot care products in the Middle East by rolling out its Compeed brand in select markets across the region.